Background {#s1}
==========

Drug discovery is a vast process, which includes various stages and trials; no wonder even after the investment of huge amount of money and time pharmaceutical companies takes decades to launch a new product to the market \[[@R01]\]. Among all these stages a very primary stage is the drug target identification process under which we screen possible drug targets within a pathogen without harming the host; therefore for this a clear understanding of host-pathogen interactions is required. Human genome sequencing as well as sequencing of many pathogens in the recent years has produced a huge amount of data, which are quite useful for comparing both human and pathogenic at genomic level, and with the modern computational techniques this comparison can be done in no time \[[@R02], [@R03]\]. Thus filtering out huge number of protein has become much easier and convenient leaving very less number of proteins for wet lab cross validation saving both time and money.

There are many existing computational techniques for drug target identification known but only some are fully automated. T-iDT is one such potential drug target identification tool validated in Mycobacterium tuberculosis \[[@R04]\], which extracts drug targets, which are essential and non, homologous to human by comparing data with the Database of Essential Genes (DEG) \[[@R05]\] and human protein database. But it is stand-alone software and will not show updates of DEG database, which can only be done manually. Here, we have designed a Perl program named Dtar-Finder and fully automated the subtractive genomic approach for drug target identification in bacteria \[[@R06], [@R07], [@R08]\]. Dtar-Finder performs the following functions: 1) Identification of drug targets in bacteria 2) Characterization of the identified targets based on its druggability and broad-spectrum ability. This program is scripted under 6 modules where module 1- 4 identifies probable drug target candidates and module 5-6 characterizes the identified targets. The objective of this program is to not only to screen non-homologous human proteins (eliminates the chances of cross-reactivity of drug with similar human protein) and essential protein (required for bacterial survival) \[[@R09]\] but also filter out proteins homologous to anti-targets (human essential proteins) \[[@R10]\] and human gut microbiota (resides in gastrointestinal tract of healthy human) \[[@R11]\]. Special feature added in Dtar-Finder also characterized the identified targets on the basis of its druggability (homology search against Drugbank database) and broad-spectrum ability (homology search against pathogen database). Further, we have tested the performance of this userfriendly robust program.

Methodology {#s2}
===========

Perl code scripting and designing: {#s2a}
----------------------------------

Dtar-Finder program (Dtar-Finder.pl) is available at https://gist.github.com/rati/ along with its instruction manual at https://gist.github.com/rati/ for the users. The overall workflow of Dtar-Finder is presented by [Figure 1](#F1){ref-type="fig"}. This program is scripted in Perl language and runs under UNIX environment. As this code automatically runs Blastp program under set criteria of E-value and percentage identity therefore, NCBI-BLAST-2.2.25+ package was installed earlier into the system \[[@R12]\]. We have utilized several UNIX Shell commands required for trimming different files under this code. The protein files required were provided in fasta file format where each sequences starts with \"\>\" (greater than symbol) with sequence id and description and entire protein sequences are kept in next single line which were manually achieved. Six databases has been downloaded and provided as reference files to the Blastp program and these are as follows: 1) non-redundant database of H. sapiens 2) essential genes from Database of essential genes 10.0 \[[@R05]\], 3) anti-targets (essential proteins) of a host (n=210), 4) human gut microbiota (n=66) \[[@R10]\], 5) targets from DrugBank 3.0 \[[@R13]\], 6) pathogen proteins (n=223) \[[@R10]\]. Dtar-Finder provides user-friendly environment where 1) User can customize BLAST criteria such as E-value and percentage identity etc 2) User can download and provide the program an updated version of database. The performance of the program was tested on 100 protein dataset (known drug target: non-drug target (50:50 ratio)) collected from literature and sensitivity (true positive rate) and specificity (true negative rate) of the output is calculated. Further, we have also predicted the potential drug targets and its characterization on 3572 reference protein sequences of C. botulinum (strain Hall/ ATCC 3502/ NCTC 13319/ Type A) \[[@R14]\].

Sensitivity (SN) = TP/(TP+FN)

Specificity (SP) = TN/(FP+TN)

Where, TP= True positive; TN= True negative; FN= False negative and FP= False positive

Output: {#s3}
=======

Dtar-Finder produces 3 result files (1) drug_targets.fasta - It carries potential drug targets ID and their corresponding sequence in the fasta format (2) drugability_result.fasta - It carries homologous drug bank targets (3) broad_spectrum_result - It carries the number of homologous pathogens against each target. The calculated sensitivity and specificity for the 100 protein dataset validates the performance of the program tabulated in [Table 1](#T1){ref-type="table"} which clearly shows that the specificity score is having better results compared to sensitivity. Also, for 3572 proteins of C. botulinum, 35 potential drug targets have been predicted, out of which 16 drug targets were broad spectrums candidates and 8 drug targets were found to be druggable while remaining were seemed to be \'novel\' targets ([Table 2](#T2){ref-type="table"}). These results were further cross-validated through literature and 27 drug targets with similar functions (functionality of 3 hypothetical proteins were predicted using INTERPROSCAN) \[[@R15]\] were found to be acting as a drug target in other bacteria whereas 8 targets did not show any result. That means the cross validation produced results with 77.14% of accuracy.

Caveats: {#s4}
========

Dtar-Finder provides results, which are fully computational, based and uses BLAST program for sequence similarity search hence; all the limitations related to this in-silico techniques are equally applicable to this script output. Here, we have collected reference files from different databases therefore all the limitations related with these databases are again applicable to our script result. Although the sensitivity and specificity scores are better but still needs further improvement. Also a detail investigation and wet lab validation of the result is required.

Future development: {#s5}
===================

In future we can further include other qualitative characterization features such as cellular localization, functionality analysis of hypothetical proteins, etc in the later version of Dtar-Finder.
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###### Performance of Dtar-Finder against 100 protein dataset

  Category                 Sensitivity   Specificity
  ------------------------ ------------- -------------
  Drug targets             0.76          0.94
  Druggability             0.92          1
  Broad spectrum ability   0.86          0.9

###### List of potential drug targets and qualitative characterization in C. botulinum using Dtar-Finder.

  Target No.   NCBI ID     Gene Product Definition                           Broad spectrum ability   Druggablility   Drugbank target
  ------------ ----------- ------------------------------------------------- ------------------------ --------------- --------------------------------
  1            148378250   sensor histidine kinase                           109(Yes)                 Druggable       P52687, Q9X180
  2            148378251   response regulator                                120(Yes)                 Druggable       P41789, P13632
  3            148378307   AraC family transcriptional regulator             91(No)                   Novel           \-
  4            148378313   iron compound ABC transporter permease            89(No)                   Novel           \-
  5            148378314   iron compound ABC transporter permease            92(No)                   Novel           \-
  6            148378317   iron dependent repressor                          79(No)                   Novel           \-
  7            148378526   Amino acid/polyamine transporter I                84(No)                   Novel           \-
  8            148378616   rod shape-determining protein RodA                151(Yes)                 Novel           \-
  9            148378703   AraC family transcriptional regulator             93(No)                   Novel           \-
  10           148378747   LysM domain-containing protein                    11(No)                   Novel           \-
  11           148378755   TetR family transcriptional regulator             34(No)                   Novel           \-
  12           148378828   RNA polymerase sigma-70 factor, ECF family        113(Yes)                 Novel           \-
  13           148378842   GNAT family acetyltransferase                     132(Yes)                 Novel           \-
  14           148378872   transcription antiterminator                      58(No)                   Druggable       P39805
  15           148378881   spore coat protein                                64(no)                   Novel           \-
  16           148378955   molybdenum ABC transporter permease               135(Yes)                 Novel           \-
  17           148379137   ABC transporter permease                          126(Yes)                 Novel           \-
  18           148379139   Peptidase                                         100(Yes)                 Novel           \-
  19           148379181   AraC family transcriptional regulator             105(Yes)                 Druggable       P0A9E0
  20           148379182   Major facilitator superfamily domain              44(No)                   Novel           \-
  21           148379348   FUR family transcriptional regulator              147(Yes)                 Novel           \-
  22           148379637   phage regulatory protein                          1(No)                    Novel           \-
  23           148380009   transferase, hexapeptide repeat family            152(Yes)                 Druggable       P43886, Q0WKM4
  24           148380045   DNA helicase                                      187(Yes)                 Novel           \-
  25           148380184   oligopeptide transporter OPT family               43(No)                   Novel           \-
  26           148380317   phage integrase                                   165(Yes)                 Novel           \-
  27           148380349   Resolvase                                         96(No)                   Novel           \-
  28           148380661   glycosyl transferase family protein               36(No)                   Novel           \-
  29           148380668   glycosyl transferase family protein               77(No)                   Novel           \-
  30           148380673   dTDP-4-dehydrorhamnose 3,5-epimerase              120(Yes)                 Druggable       P26394, Q9HU21, O06330, O52806
  31           148380679   3-deoxy-manno-octulosonate cytidylyltransferase   102(Yes)                 Druggable       P44490, P42216
  32           148380686   6-hydroxymethylpterin diphosphokinase MptE-like   19(No)                   Novel           \-
  33           148380687   Glycosyltransferase                               135(Yes)                 Novel           \-
  34           148380997   alginate O-acetyltransferase AlgI                 84(No)                   Novel           \-
  35           148381302   diguanylate cyclase                               83(No)                   Druggable       Q9A5I5

![Flowchart representing the architecture of Dtar-Finder program for the identification of potential targets, druggability and broadspectrum ability in bacteria using subtractive genomics approach.](97320630015209F1){#F1}
